Regenxbio Inc (RGNX)
7.63
+0.22
(+2.97%)
USD |
NASDAQ |
Dec 20, 16:00
7.71
+0.08
(+1.05%)
After-Hours: 20:00
Regenxbio Total Liabilities (Quarterly): 217.70M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 111.07M |
| Vertex Pharmaceuticals Inc | 6.609B |
| Sarepta Therapeutics Inc | 2.379B |
| Edgewise Therapeutics Inc | 22.40M |
| Entrada Therapeutics Inc | 132.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 519.11M |
| Shareholders Equity (Quarterly) | 301.42M |
| Current Ratio | 3.051 |